These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 23425047)

  • 1. Optimizing biologically targeted clinical trials for neurofibromatosis.
    Gutmann DH; Blakeley JO; Korf BR; Packer RJ
    Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis-related tumors: emerging biology and therapies.
    Karajannis MA; Ferner RE
    Curr Opin Pediatr; 2015 Feb; 27(1):26-33. PubMed ID: 25490687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenesis in neurofibromatosis: new insights and potential therapies.
    Reed N; Gutmann DH
    Trends Mol Med; 2001 Apr; 7(4):157-62. PubMed ID: 11286939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis.
    McClatchey AI
    Annu Rev Pathol; 2007; 2():191-216. PubMed ID: 18039098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
    Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
    Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).
    Shen YC; Arellano-Garcia C; Menjivar RE; Jewett EM; Dohle W; Karchugina S; Chernoff J; Potter BVL; Barald KF
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):67. PubMed ID: 31730023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.
    Hakimi MA; Speicher DW; Shiekhattar R
    J Biol Chem; 2002 Oct; 277(40):36909-12. PubMed ID: 12191989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurofibromatoses: when less is more.
    Gutmann DH
    Hum Mol Genet; 2001 Apr; 10(7):747-55. PubMed ID: 11257108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Detection of
    Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the neurofibromatoses.
    Gutmann DH
    Curr Opin Neurol; 1994 Apr; 7(2):166-71. PubMed ID: 8019663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1.
    Cimino PJ; Gutmann DH
    Handb Clin Neurol; 2018; 148():799-811. PubMed ID: 29478615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.
    Bettegowda C; Upadhayaya M; Evans DG; Kim A; Mathios D; Hanemann CO;
    Neurology; 2021 Aug; 97(7 Suppl 1):S91-S98. PubMed ID: 34230207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
    Blakeley JO; Plotkin SR
    Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.
    Osum SH; Watson AL; Largaespada DA
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis.
    Gerber PA; Antal AS; Neumann NJ; Homey B; Matuschek C; Peiper M; Budach W; Bölke E
    Eur J Med Res; 2009 Mar; 14(3):102-5. PubMed ID: 19380279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.